youtube_live
Q2 2027 earnings • 2:00 AM tomorrow
See detailschevron_right
4503:TYO
Astellas Pharma Inc
ÂĄ2,569.00
arrow_downward
-0.08%(-2.00) 1D
Nov 2, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4503...
Open
ÂĄ2,594
High
ÂĄ2,611
Low
ÂĄ2,556
Mkt. cap
4.65T
Avg. vol.
5.91M
Volume
4.69M
Dividend
3.04%
Quarterly dividend
ÂĄ19
Ex-dividend date
Sep 29, 2026
P/E ratio
12.61
52-wk high
ÂĄ2,717
52-wk low
ÂĄ1,637
EPS
ÂĄ204
Shares outstanding
1.92B
No. of employees
14K
Open
ÂĄ2,594
High
ÂĄ2,611
Low
ÂĄ2,556
Mkt. cap
4.65T
Avg. vol.
5.91M
Volume
4.69M
Dividend
3.04%
Quarterly dividend
ÂĄ19
Ex-dividend date
Sep 29, 2026
P/E ratio
12.61
52-wk high
ÂĄ2,717
52-wk low
ÂĄ1,637
EPS
ÂĄ204
Shares outstanding
1.92B
No. of employees
14K
News stories
From web sources and news partners
Investing.com
·
38 minutes ago
MediWound’s EscharEx Strategy May Be Ahead of the Game as FDA Puts Chronic Wounds in Focus (Nasdaq: MDWD)
www.marketscreener.com
·
1 hour ago
NYSE-Affiliated Venue for Tokenization Adds Transfer Agents: NYSE Content Update
Seeking Alpha
·
3 minutes ago
Most shorted stocks on Wall Street
Barchart.com
·
2 hours ago
Upstart (NASDAQ:UPST) posts better-than-expected sales in Q3 2026, stock soars
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com